phenylephrine-hydrochloride and Diabetes-Mellitus--Type-1

The objective of this study was to compare prophylaxis for Staphylococcus aureus infections in peritoneal dialysis patients using 600 mg cyclic oral rifampin for 5 days every 3 months versus mupirocin calcium ointment 2% applied daily to the exit site. The study design was a prospective randomized trial, controlling for S aureus nasal carriage. Eighty-two continuous ambulatory and continuous cyclic peritoneal dialysis patients (54% male, 71 % white, 34% insulin-dependent, mean prestudy time on peritoneal dialysis 1.2 years) were randomly assigned to cyclic rifampin (n = 41 patients) or daily exit site mupirocin prophylaxis (n = 41 patients). Mean follow-up was 1 year. S aureus catheter infection rates were 0.13/yr with mupirocin and 0.15/yr with rifampin (P = NS). Both rates were significantly lower than the center's historical rate (the period between 1983 and 1992) of 0.46/yr prior to the study (P < 0.001). S aureus peritonitis rates were 0.04/yr with mupirocin and 0.02/yr with rifampin (P = NS), both significantly lower than the center's historical rate of 0.16/yr (P < 0.02). Catheter loss due to S aureus infections was 0.02/yr with mupirocin and 0/yr with rifampin (P = NS), both significantly lower than the center's historical rate of 0.12/yr (P < 0.001). There were no side effects in patients using mupirocin, but 12% were unable to continue rifampin due to side effects. We conclude that mupirocin ointment at the exit site and cyclic oral rifampin are equally effective in reducing S aureus catheter infections. In addition, rifampin or mupirocin significantly reduced S aureus peritonitis and catheter loss due to S aureus infections. Mupirocin at the exit site provides an excellent alternative prophylaxis for S aureus infections, particularly in patients who cannot tolerate oral rifampin therapy.

Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Chemoprevention; Diabetes Mellitus, Type 1; Drug Administration Schedule; Equipment Contamination; Equipment Failure; Female; Follow-Up Studies; Humans; Male; Mupirocin; Nose; Ointments; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus

The aim of this prospective study was to establish the methicillin-resistant Staphylococcus aureus (MRSA) colonization rates in pediatric outpatients with type 1 diabetes mellitus, while also evaluating changes in colonization rates over time. There was no significant difference between 2005 and 2013 patients in terms of demographic and clinical findings. MRSA colonization rates were 0.7% (in 101 patients) and 0.9% (in 134 patients) (P = .84). Although increased MRSA colonization has become a significant problem worldwide, it does not seem to be a major issue in our diabetic outpatient population.

Topics: Adolescent; Carrier State; Child; Diabetes Mellitus, Type 1; Female; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Nose; Outpatients; Prevalence; Prospective Studies; Staphylococcal Infections

Polymorphisms in the vitamin D receptor (VDR) gene have been associated with susceptibility to several diseases, including type 1 diabetes (T1D) and infections. In this study we investigated whether VDR gene polymorphisms influence nasal carriage of Staphylococcus aureus in individuals with T1D.. In 93 T1D patients, VDR polymorphisms on FokI F>f, BsmI B>b, ApaI A>a, and TaqI T>t were determined in DNA extracted from peripheral blood leukocytes, and a nasal swab was obtained to detect colonization by S. aureus. A repeat swab was obtained in 76/93 subjects for the estimation of persistent S. aureus carriage.. The prevalence of S. aureus nasal colonization was 31.2% and the prevalence of persistent carriage was 25%. The presence of TaqI T allele was related to higher rates of S. aureus colonization, and TaqI TT homozygotes were more colonized (48.5% vs. 21.7%; p 0.007; OR 3.40, 95% CI 1.36-8.52) and more persistent carriers (37.9% vs. 17.0%; p 0.039; OR 2.98, 95% CI 1.02-8.67). The presence of ApaI A allele was related to lower rates of S. aureus colonization, and ApaI AA homozygotes were less colonized (17.6% vs. 39.0%; p 0.026; OR 0.34, 95% CI 0.12-0.94) and less persistent carriers (11.5% vs. 32%; p 0.043; OR 0.28, 95% CI 0.07-1.06). No differences were observed for BsmI and FokI genotypes.. Our findings suggest that VDR polymorphisms may be associated with nasal carriage of S. aureus in individuals with T1D, and further contribute to the better understanding of the immunomodulatory role of vitamin D in the human host's response and susceptibility to infection.

Topics: Adolescent; Adult; Carrier State; Child; Child, Preschool; Diabetes Complications; Diabetes Mellitus, Type 1; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Nose; Polymorphism, Genetic; Prevalence; Receptors, Calcitriol; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Young Adult

To evaluate the importance of nasal carriage of Staphylococcus aureus as a risk factor for the development of wound infection at the sternotomy site after cardiac surgery, a case-control study was done. The study population consisted of 1980 consecutive patients. Cases were all patients who developed a sternal wound infection from which S. aureus was cultured. Forty cases were identified, and 120 controls were selected. Preoperative nasal carriage of S. aureus, insulin-dependent diabetes mellitus, and younger age were identified as significant risk factors. The crude odds ratio of nasal carriage was 9.6 (95% confidence interval, 3.9-23.7). The median postoperative length of hospital stay for cases was 30 days longer than for controls. Mortality was also significantly higher for cases than for controls (10.0% and 0.8%, respectively).

Topics: Bacteriophage Typing; Cardiac Surgical Procedures; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Humans; Length of Stay; Male; Nose; Odds Ratio; Risk Factors; Staphylococcus aureus; Surgical Wound Infection

We compared a group of 60 insulin-dependent diabetics maintained on CAPD with 60 nondiabetic matched controls to determine if the diabetic patients were at increased risk for catheter-related infections. Although catheter infection rates were 17% higher in the diabetics (1.4/year versus 1.2/year in nondiabetics), time to first catheter infection was not different between the groups (p = 0.6). Rates of peritonitis, peritonitis associated with catheter infection, multiple catheter infection, and catheter removal were also similar among the diabetics and controls. S. aureus caused 52% (42/81) of the catheter infections in the diabetics and 60% (35/58) in the controls. More catheter infections in the nondiabetics versus the diabetics lacked drainage or resulted in sterile cultures (17/75 versus 7/88 respectively, p less than or equal to 0.01), but the significance of this finding is uncertain. In conclusion, we did not find insulin-dependent diabetes mellitus to be a statistically significant risk factor for catheter-related infections.

Topics: Bacterial Infections; Catheterization; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Nose; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Retrospective Studies; Risk Factors; Staphylococcus aureus

Topics: Child; Diabetes Mellitus, Type 1; Exophthalmos; Female; Granulomatosis with Polyangiitis; Hematuria; Humans; Nose; Proteinuria